Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,981-16,992 of 23,847
Drug study icon
CompletedNCT02703363

Minocycline and Celecoxib as Adjunctive Treatments of Depression in bipolarity

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In Karachi
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02968602

Minocycline and Tobacco Craving in Smokers With Schizophrenia

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.

In Catonsville
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT03947827

Minocycline as Adjunctive Treatment for Treatment Resistant Depression

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Toronto
DepressionDrugFrom 18 Years to 80 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
Drug study icon
CompletedNCT02124811

Minocycline Augmentation to Clozapine

This summary needs review. Please check the official study record and contact the research team for details.

In Atlanta
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
Drug study icon
WithdrawnNCT03244592

Minocycline for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
AddictionDrugFrom 21 Years to 55 Years
Countries
Sponsor
University of California, Los Angeles
Condition
Addiction
Drug study icon
CompletedNCT01514422

Minocycline for Depression in bipolarity

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

In New York
Bipolarity, DepressionDrugFrom 18 Years to 68 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01809158

Minocycline for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Addis Ababa
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
Ethiopia
Sponsor
Addis Ababa University
Condition
Schizophrenia
Drug study icon
CompletedNCT03340350

Minocycline for Treatment of PTSD in Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In Omaha
PTSDDrugFrom 19 Years to 65 Years
Countries
United States
Sponsor
Sriram Ramaswamy
Condition
PTSD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.